rs910858
Variant names: 
Your query was ambiguous. Multiple possible variants found: 
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_033409.4(SLC52A3):c.1073+315C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.648 in 152,092 control chromosomes in the GnomAD database, including 33,535 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
 Genomes: 𝑓 0.65   (  33535   hom.,  cov: 34) 
Consequence
 SLC52A3
NM_033409.4 intron
NM_033409.4 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.478  
Publications
7 publications found 
Genes affected
 SLC52A3  (HGNC:16187):  (solute carrier family 52 member 3) This gene encodes a riboflavin transporter protein that is strongly expressed in the intestine and likely plays a role in intestinal absorption of riboflavin. The protein is predicted to have eleven transmembrane domains and a cell surface localization signal in the C-terminus. Mutations at this locus have been associated with Brown-Vialetto-Van Laere syndrome and Fazio-Londe disease. [provided by RefSeq, Mar 2012] 
SLC52A3 Gene-Disease associations (from GenCC):
- Brown-Vialetto-van Laere syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
- progressive bulbar palsyInheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93). 
BP6
Variant 20-763183-G-A is Benign according to our data. Variant chr20-763183-G-A is described in ClinVar as Benign. ClinVar VariationId is 1252697.Status of the report is criteria_provided_single_submitter, 1 stars. 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.847  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.648  AC: 98512AN: 151974Hom.:  33504  Cov.: 34 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
98512
AN: 
151974
Hom.: 
Cov.: 
34
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.648  AC: 98588AN: 152092Hom.:  33535  Cov.: 34 AF XY:  0.651  AC XY: 48365AN XY: 74326 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
98588
AN: 
152092
Hom.: 
Cov.: 
34
 AF XY: 
AC XY: 
48365
AN XY: 
74326
show subpopulations 
African (AFR) 
 AF: 
AC: 
17578
AN: 
41486
American (AMR) 
 AF: 
AC: 
9849
AN: 
15276
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2550
AN: 
3466
East Asian (EAS) 
 AF: 
AC: 
4477
AN: 
5154
South Asian (SAS) 
 AF: 
AC: 
3544
AN: 
4824
European-Finnish (FIN) 
 AF: 
AC: 
8064
AN: 
10562
Middle Eastern (MID) 
 AF: 
AC: 
222
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
50208
AN: 
68010
Other (OTH) 
 AF: 
AC: 
1408
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.501 
Heterozygous variant carriers
 0 
 1699 
 3398 
 5097 
 6796 
 8495 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 794 
 1588 
 2382 
 3176 
 3970 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
2653
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
not provided    Benign:1 
Jul 03, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.